IVD Technology

Nigeria Urged to End Reliance on Imported Diagnostic Reagents
Imaging & Diagnostics Nigeria Urged to End Reliance on Imported Diagnostic Reagents

In a striking revelation that underscores a critical vulnerability in Nigeria’s healthcare system, experts have highlighted the nation’s overwhelming dependence on imported diagnostic reagents, spending billions of limited foreign reserves annually to sustain this need. This issue, brought to the

IVD Quality Control Market to Hit $2.15 Billion by 2030
Imaging & Diagnostics IVD Quality Control Market to Hit $2.15 Billion by 2030

Imagine a world where diagnostic tests for critical health conditions are unreliable, leading to misdiagnoses and delayed treatments—a scenario that could have devastating consequences for patients and healthcare systems alike. This pressing concern underscores the vital importance of quality

Will Siemens’ $7 Billion Diagnostics Sale Reshape Healthcare?
Imaging & Diagnostics Will Siemens’ $7 Billion Diagnostics Sale Reshape Healthcare?

The healthcare industry is currently gripped by speculation over Siemens Healthineers’ potential decision to sell its diagnostics division for a staggering amount exceeding $7 billion, a move that could send shockwaves through the in vitro diagnostics (IVD) market. This possible transaction,

Unnecessary Data Burdens Clinical Trials, Study Finds
Imaging & Diagnostics Unnecessary Data Burdens Clinical Trials, Study Finds

Imagine a clinical trial where every participant must navigate a maze of assessments, travel long distances, and adjust their daily routines, only to discover that much of the information collected isn’t even essential to the study’s core goals. A recent working paper from the Tufts Center for the

Can CNSide's New Test Transform CNS Cancer Detection?
Imaging & Diagnostics Can CNSide's New Test Transform CNS Cancer Detection?

In the realm of cancer diagnostics, few challenges are as daunting as detecting central nervous system (CNS) cancers, particularly those that metastasize to the brain or spine from other parts of the body like carcinomas and melanomas, often leaving patients with limited treatment options. For

How Will $600,000 Boost Oklahoma City's Biotech Boom?
Imaging & Diagnostics How Will $600,000 Boost Oklahoma City's Biotech Boom?

In a transformative move for Oklahoma City’s burgeoning biotech landscape, a substantial $600,000 allocation from the Oklahoma City Economic Development Authority is set to catalyze the creation of a $46.7 million medical research lab by ARL Bio Pharma. This ambitious project not only promises to

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later